When Trova Wine and Market shut its doors last month after nearly five years in business in Dallas, owner Michelle Bonds pointed to an unexpected reason for closure: GLP-1 weight loss drugs like ...

A majority with overweight/obesity discontinue within a year, but the rate is higher among those without type 2 diabetes.

A well-known class of drugs used to manage type 2 diabetes and control weight could offer hope for patients who also struggle ...

"They’re priced for profits, not patients.” That’s the critique from Hims & Hers Health’s buzzy — and controversial — Super ...

In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial ...

Objective—Glucagon-like peptide 1 (GLP-1) exerts beneficial antidiabetic actions via effects on pancreatic β- and α-cells. Previous studies have focused on the improvements in β-cell function ...

About The Study: This cross-sectional study showed websites that sell compounded glucagon-like peptide-1 receptor agonists ... Compounded medications contain the same active ingredients as ...

Compounded weight-loss medications, such as those promoted in the Hims & Hers commercial, aren’t approved by the Food and ...

Glucagon-like peptide-1 receptor (GLP-1) agonists — which contain either semaglutide or ... but previous studies have linked the drugs to other, unexpected benefits. Researchers at Washington ...

Rani Therapeutics (RANI) announced new pharmacokinetic and pharmacodynamic data from a preclinical study evaluating the oral delivery of the ...